Congenital adrenal hyperplasia and lower urinary tract symptoms

BJU International

Volumn 95, Issue 9, 2005, Pages 1263-1266

  Davies, Melissa C ^a   Crouch, Naomi S ^a   Woodhouse, Christopher R J ^b   Creighton, Sarah M ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c Napolitano and Prof David)   (United Kingdom)

Author keywords

Congenital adrenal hyperplasia; Incontinence; Urinary symptoms

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BRISTOL FEMALE LOWER URINARY TRACT SYMPTOMS QUESTIONNAIRE; CLINICAL ARTICLE; CONGENITAL ADRENAL HYPERPLASIA; CONTROLLED STUDY; FEMALE; HUMAN; PLASTIC SURGERY; PRIORITY JOURNAL; QUESTIONNAIRE; STRESS INCONTINENCE; URGE INCONTINENCE;

ADOLESCENT; ADRENAL HYPERPLASIA, CONGENITAL; ADULT; CASE-CONTROL STUDIES; FEMALE; GENITALIA, FEMALE; HUMANS; URINARY INCONTINENCE;

EID: 20444382082     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2005.05516.x     Document Type: Article

References (17)

1. Hughes IA. Management of congenital adrenal hyperplasia. Arch Dis Child 1988; 63: 1399-404
2. de Jong TP, Boemers TM. Neonatal management of female intersex by clitorovaginoplasty. J Urol 1995; 154: 830-2
3. Anonymous. Consensus statement on 21-hydroxylase deficiency from the Lawson Wilkins Pediatric Endocrine Society and the European Society for Pediatric Endocrinology. J Clin Endocrinol Metab 2002; 87: 4048-53
4. Jackson S, Donovan J, Brookes S, Eckford S, Swithinbank L, Abrams P. The Bristol Female Lower Urinary Tract Symptoms questionnaire, development and psychometric testing. Br J Urol 1996; 77: 805-12
5. Edwards P, Roberts I, Clarke M et al. Increasing response rates to postal questionnaires: systematic review. BMJ 2002; 324: 1183-6
6. Joint Formulary Committee. British National Formulary, 47th edn. London: British Medical Association and Royal Pharmaceutical of Great Britain, 2004
7. Hannestad YS, Rortveit G, Sandvik H, Hunskaar S. A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. Epidemiology of Incontinence in the County of Nord-Trondelag. J Clin Epidemiol 2000; 53: 1150-7
8. Wisniewski AB, Migeon CJ, Malouf MA, Gearhart JP. Psychosexual outcome in women affected by congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Urol 2004; 171: 2497-501
9. Celayir S, Ilce Z, Danismend N. Effects of male sex hormones on urodynamics in childhood: intersex patients are a natural model. Pediatr Surg Int 2000; 16: 502-4
10. Stikkelbroeck NM, Beerendonk CC, Willemsen WN et al. The long term outcome of feminizing genital surgery for congenital adrenal hyperplasia: anatomical, functional and cosmetic outcomes, psychosexual development, and satisfaction in adult female patients. J Pediatr Adolesc Gynecol 2003; 16: 289-96
11. Conway GS, Mouriquand PDE. Congenital adrenal hyperplasia. In Balen AH ed. Paediatric and Adolescent Gynaecology: a Multidisciplinary Approach. Cambridge: Cambridge University Press, 2004: 310-26
12. Thiruchelvam N, Cuckow PM. Normal bladder control and function. In Balen AH ed. Paediatric and Adolescent Gynaecology: a Multidisciplinary Approach. Cambridge: Cambridge University Press, 2004: 65-76
13. Rhodes T, Girman CJ, Jacobsen SJ et al. Does the mode of questionnaire administration affect the reporting of urinary symptoms? Urology 1995; 46: 341-5
14. Rodriguez LV, Blander DS, Dorey F, Raz S, Zimmern P. Discrepancy in patient and physician perception of patient's quality of life related to urinary symptoms. Urology 2003; 62: 49-53
15. Creighton SM, Minto CL, Steele SJ. Objective cosmetic and anatomical outcomes at adolescence of feminising surgery for ambiguous genitalia done in childhood. Lancet 2001; 358: 124-5
16. Farkas A, Rosler A. Ten years experience with masculinizing genitoplasty in male pseudohermaphroditism due to 17 beta-hydroxysteroid dehydrogenase deficiency. Eur J Pediatr 1993; 152 (Suppl. 2): S88-S90
17. Pesce F. Current management of stress urinary incontinence. BJU Int 2004; 94 (Suppl. 1): 8-13